Cervical Cancer Querleu-Morrow Radical Hysterectomy Type — free guideline decision tool
Standardise radical hysterectomy by lateral parametrial resection extent (Querleu-Morrow A/B/C/D), with resection landmarks, nerve handling and typical indications. Instant, browser-side.
Open guideline tool →Guideline-based
Implements the decision logic from published clinical guidelines.
Runs in your browser
No installation. Enter the patient's values and get a guideline recommendation instantly.
Data stays local
Nothing is uploaded. Results are for licensed clinicians only.
Worked calculation
The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.
| Surgical type | A — minimal resection |
|---|
→Q-M typeType A
- Type:Type A (minimal resection)
- Resection landmark:Paracervix transected medial to the ureter (between cervix and ureter)
- Nerve handling:Autonomic nerves not involved, bladder branches preserved
| Surgical type | D — laterally extended resection (LEER) |
|---|
→Q-M typeType D
- Type:Type D (laterally extended resection)
- Resection landmark:Entire paracervix resected at the pelvic wall (incl. internal iliac vessels; D2/LEER also adjacent fascia/muscle)
- Nerve handling:Nerves sacrificed, resection reaches the pelvic wall
Common questions
What is Cervical Cancer Querleu-Morrow Radical Hysterectomy Type?
Standardise radical hysterectomy by lateral parametrial resection extent (Querleu-Morrow A/B/C/D), with resection landmarks, nerve handling and typical indications. Instant, browser-side.
How is Cervical Cancer Querleu-Morrow Radical Hysterectomy Type calculated? What is the core formula?
A minimal (medial to ureter); B at ureteric level (B1 / B2 + paracervical nodes); C at internal-iliac junction (C1 nerve-sparing preferred / C2 non-sparing); D laterally extended pelvic-wall resection (LEER).
When is Cervical Cancer Querleu-Morrow Radical Hysterectomy Type used?
Communicate and standardise the radicality of radical hysterectomy for cervical cancer using the Querleu-Morrow classification.
What are the key clinical points for Cervical Cancer Querleu-Morrow Radical Hysterectomy Type?
The classification is defined by how far laterally the parametrium is resected, replacing the older Piver-Rutledge system. Type C1 (nerve-sparing) is the preferred standard radical procedure; C2 sacrifices autonomic nerves and causes more voiding/rectal dysfunction. Voiding and rectal dysfunction broadly increase from type A through C2. The 2017 update reinforced C1 as the preferred type-C operation, reserving C2 for when nerves cannot be spared.
What are the limits and cautions when using Cervical Cancer Querleu-Morrow Radical Hysterectomy Type?
For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
How is Cervical Cancer Querleu-Morrow Radical Hysterectomy Type calculated in practice? Can you show a worked example?
Inputs: Surgical type A — minimal resection → Result: Q-M type Type A(Type: Type A (minimal resection), Resection landmark: Paracervix transected medial to the ureter (between cervix and ureter), Nerve handling: Autonomic nerves not involved, bladder branches preserved) Inputs: Surgical type D — laterally extended resection (LEER) → Result: Q-M type Type D(Type: Type D (laterally extended resection), Resection landmark: Entire paracervix resected at the pelvic wall (incl. internal iliac vessels; D2/LEER also adjacent fascia/muscle), Nerve handling: Nerves sacrificed, resection reaches the pelvic wall)
Run Cervical Cancer Querleu-Morrow Radical Hysterectomy Type now
Standardise radical hysterectomy by lateral parametrial resection extent (Querleu-Morrow A/B/C/D), with resection landmarks, nerve handling and typical indications. Instant, browser-side.
Open guideline tool →For licensed clinicians. Not a substitute for clinical judgement.
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.